Acadia Healthcare Company, Inc. Deferred Federal Income Tax Expense (Benefit)
Acadia Healthcare Company, Inc. (ACHC) reported Deferred Federal Income Tax Expense (Benefit) of -$32.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-27
- Acadia Healthcare Company, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$32.25M, a 150.77% decline from fiscal 2024.
- Acadia Healthcare Company, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was $63.53M.
- Acadia Healthcare Company, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$72.05M, a 834.56% decline from fiscal 2022.
- Acadia Healthcare Company, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was $9.81M, a 26.47% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$32.25M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $63.53M 10-K · filed 2026-02-27 | |
| 2023-12-31 | -$72.05M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $9.81M 10-K · filed 2025-02-27 | |
| 2021-12-31 | $13.34M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $46.44M 10-K · filed 2023-02-28 | |
| 2019-12-31 | -$1.57M 10-K · filed 2022-03-01 | -$1.57M 10-K · filed 2020-02-28 |
| 2018-12-31 | -$7.18M 10-K · filed 2021-02-26 | |
| 2017-12-31 | $27.18M 10-K · filed 2020-02-28 | |
| 2016-12-31 | $45.08M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $40.63M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $2.67M 10-K · filed 2017-02-24 | |
| 2013-12-31 | $7.80M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $3.14M 10-K · filed 2015-02-27 | |
| 2011-12-31 | -$5.03M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Concentra Group Holdings Parent, Inc. (CON) | United States | $4.417B | 19.11 |